CORD-19:185e78aee848db9cc3a4510619048a6e4acd22cc / 2893-3141 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T15","span":{"begin":0,"end":248},"obj":"Sentence"}],"text":"Management with intravenous corticosteroids and intensive supportive care was associated with resolution within 24 hours of onset in the present series. cytokine production, including increased tumor necrosis factor-a, interleukin (IL)-6, and IL-8."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T15","span":{"begin":0,"end":248},"obj":"Sentence"},{"id":"TextSentencer_T15","span":{"begin":0,"end":248},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Management with intravenous corticosteroids and intensive supportive care was associated with resolution within 24 hours of onset in the present series. cytokine production, including increased tumor necrosis factor-a, interleukin (IL)-6, and IL-8."}

{"project":"Epistemic_Statements","denotations":[{"id":"T5","span":{"begin":0,"end":152},"obj":"Epistemic_statement"}],"text":"Management with intravenous corticosteroids and intensive supportive care was associated with resolution within 24 hours of onset in the present series. cytokine production, including increased tumor necrosis factor-a, interleukin (IL)-6, and IL-8."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T29","span":{"begin":74,"end":77},"obj":"Disease"},{"id":"T30","span":{"begin":194,"end":199},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"Management with intravenous corticosteroids and intensive supportive care was associated with resolution within 24 hours of onset in the present series. cytokine production, including increased tumor necrosis factor-a, interleukin (IL)-6, and IL-8."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T18","span":{"begin":194,"end":199},"obj":"Phenotype"}],"attributes":[{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Management with intravenous corticosteroids and intensive supportive care was associated with resolution within 24 hours of onset in the present series. cytokine production, including increased tumor necrosis factor-a, interleukin (IL)-6, and IL-8."}